{"id":"https://openalex.org/W3022650708","doi":"https://doi.org/10.3389/fonc.2020.00696","title":"Low-Dose Crizotinib, a Tyrosine Kinase Inhibitor, Highly and Specifically Sensitizes P-Glycoprotein-Overexpressing Chemoresistant Cancer Cells Through Induction of Late Apoptosis in vivo and in vitro","display_name":"Low-Dose Crizotinib, a Tyrosine Kinase Inhibitor, Highly and Specifically Sensitizes P-Glycoprotein-Overexpressing Chemoresistant Cancer Cells Through Induction of Late Apoptosis in vivo and in vitro","publication_year":2020,"publication_date":"2020-05-12","ids":{"openalex":"https://openalex.org/W3022650708","doi":"https://doi.org/10.3389/fonc.2020.00696","mag":"3022650708","pmid":"https://pubmed.ncbi.nlm.nih.gov/32528877","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7247847"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2020.00696","doi":"https://doi.org/10.3389/fonc.2020.00696","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2020.00696","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2020.00696/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3022650708"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2020.00696/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052020438","display_name":"Kyeong Seok Kim","orcid":"https://orcid.org/0009-0009-0867-8450","observed_orcids":["https://orcid.org/0009-0009-0867-8450"]},"institutions":[{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Kyeong Seok Kim","raw_affiliation_strings":["School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea","institution_ids":["https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033044012","display_name":"Chunxue Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Chunxue Jiang","raw_affiliation_strings":["School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea","institution_ids":["https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109675730","display_name":"Ji Young Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Ji Young Kim","raw_affiliation_strings":["School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea","institution_ids":["https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100701465","display_name":"Jae Hyeon Park","orcid":"https://orcid.org/0000-0002-8463-6086","observed_orcids":["https://orcid.org/0000-0002-8463-6086"]},"institutions":[{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jae Hyeon Park","raw_affiliation_strings":["School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea","institution_ids":["https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053504786","display_name":"Hae-Ri Kim","orcid":"https://orcid.org/0000-0001-8766-6064","observed_orcids":["https://orcid.org/0000-0001-8766-6064","https://orcid.org/0000-0002-2173-0016"]},"institutions":[{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Hae Ri Kim","raw_affiliation_strings":["School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea","institution_ids":["https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100381291","display_name":"Su Hyun Lee","orcid":"https://orcid.org/0000-0002-0171-8060","observed_orcids":["https://orcid.org/0000-0002-0171-8060"]},"institutions":[{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Su Hyun Lee","raw_affiliation_strings":["School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea","institution_ids":["https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052433739","display_name":"Hyung Sik Kim","orcid":"https://orcid.org/0000-0001-7657-3970","observed_orcids":["https://orcid.org/0000-0001-7657-3970"]},"institutions":[{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":true,"raw_author_name":"Hyung Sik Kim","raw_affiliation_strings":["School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea","institution_ids":["https://openalex.org/I848706"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091003200","display_name":"Sungpil Yoon","orcid":"https://orcid.org/0000-0002-9301-6313","observed_orcids":["https://orcid.org/0000-0002-9301-6313"]},"institutions":[{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":true,"raw_author_name":"Sungpil Yoon","raw_affiliation_strings":["School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Sungkyunkwan University, Suwon-si, South Korea","institution_ids":["https://openalex.org/I848706"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5052433739","https://openalex.org/A5091003200"],"corresponding_institution_ids":["https://openalex.org/I848706"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.486,"has_fulltext":true,"cited_by_count":21,"citation_normalized_percentile":{"value":0.83890227,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"10","issue":null,"first_page":"696","last_page":"696"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":1.0},{"id":"https://openalex.org/keywords/p-glycoprotein-overexpression","display_name":"P-glycoprotein overexpression","score":0.9039999842643738},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8059999942779541},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.8299999833106995},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5640000104904175},{"id":"https://openalex.org/keywords/g2-cell-cycle-arrest","display_name":"G2 cell cycle arrest","score":0.7630000114440918},{"id":"https://openalex.org/keywords/kbv200-cells","display_name":"KBv200 cells","score":0.7860000133514404},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.8379999995231628},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.8629999756813049},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5770000219345093},{"id":"https://openalex.org/keywords/xenograft-tumor-growth","display_name":"xenograft tumor growth","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.8827289938926697},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.6870124340057373},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6470321416854858},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6402049660682678},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5008857250213623},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.49638205766677856},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4757285416126251},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.4521619379520416},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.44898608326911926},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4385235905647278},{"id":"https://openalex.org/C2780333294","wikidata":"https://www.wikidata.org/wiki/Q7914515","display_name":"Vandetanib","level":4,"score":0.4189970791339874},{"id":"https://openalex.org/C2776539811","wikidata":"https://www.wikidata.org/wiki/Q4830631","display_name":"Axitinib","level":4,"score":0.4128814935684204},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39266064763069153},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.24880090355873108},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1944877803325653},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.17864051461219788},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.13590273261070251},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.09912705421447754},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2020.00696","doi":"https://doi.org/10.3389/fonc.2020.00696","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2020.00696","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2020.00696/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:32528877","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32528877","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7247847","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7247847/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:e5635f5744cf4f6c97391ab547c115a8","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e5635f5744cf4f6c97391ab547c115a8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 10 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2020.00696","doi":"https://doi.org/10.3389/fonc.2020.00696","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2020.00696","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2020.00696/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7154324044","display_name":null,"funder_award_id":"2019R1A2C2002923","funder_id":"https://openalex.org/F4320322120","funder_display_name":"National Research Foundation of Korea"},{"id":"https://openalex.org/G7808506114","display_name":null,"funder_award_id":"NRF-2019R1A2C2002923","funder_id":"https://openalex.org/F4320322120","funder_display_name":"National Research Foundation of Korea"}],"funders":[{"id":"https://openalex.org/F4320320671","display_name":"National Research Foundation","ror":"https://ror.org/05s0g1g46"},{"id":"https://openalex.org/F4320322120","display_name":"National Research Foundation of Korea","ror":"https://ror.org/013aysd81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3022650708.pdf","grobid_xml":"https://content.openalex.org/works/W3022650708.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W279109021","https://openalex.org/W1599268777","https://openalex.org/W1713116419","https://openalex.org/W1881469793","https://openalex.org/W1904541254","https://openalex.org/W1963497189","https://openalex.org/W1965615508","https://openalex.org/W1971579914","https://openalex.org/W1983933325","https://openalex.org/W2011906439","https://openalex.org/W2019747410","https://openalex.org/W2038056960","https://openalex.org/W2038695289","https://openalex.org/W2049661083","https://openalex.org/W2052546787","https://openalex.org/W2055191970","https://openalex.org/W2055904567","https://openalex.org/W2069382823","https://openalex.org/W2070727232","https://openalex.org/W2072517578","https://openalex.org/W2085805439","https://openalex.org/W2091326325","https://openalex.org/W2098064809","https://openalex.org/W2111909068","https://openalex.org/W2117905001","https://openalex.org/W2138652650","https://openalex.org/W2150406132","https://openalex.org/W2174049160","https://openalex.org/W2191737540","https://openalex.org/W2310104311","https://openalex.org/W2337724218","https://openalex.org/W2343566398","https://openalex.org/W2398179343","https://openalex.org/W2412448574","https://openalex.org/W2417928840","https://openalex.org/W2543649179","https://openalex.org/W2545087866","https://openalex.org/W2545386408","https://openalex.org/W2566076681","https://openalex.org/W2595286623","https://openalex.org/W2728750609","https://openalex.org/W2744882241","https://openalex.org/W2762771781","https://openalex.org/W2890310561","https://openalex.org/W2890387348","https://openalex.org/W2890742011","https://openalex.org/W2891020281","https://openalex.org/W2895146343","https://openalex.org/W2901328308","https://openalex.org/W2953542772","https://openalex.org/W2954587962","https://openalex.org/W2955864018","https://openalex.org/W2971041600","https://openalex.org/W2979892829"],"related_works":["https://openalex.org/W2954587962","https://openalex.org/W1972001316","https://openalex.org/W1599268777","https://openalex.org/W4225272674","https://openalex.org/W2740099761","https://openalex.org/W3126814686","https://openalex.org/W2979892829","https://openalex.org/W4224293161","https://openalex.org/W4236881826","https://openalex.org/W2741571561"],"abstract_inverted_index":{").":[0],"Our":[1],"approach":[2],"utilized":[3],"repurposing":[4],"drugs,":[5],"which":[6,75],"are":[7],"already":[8],"used":[9,228],"in":[10,91,229],"clinical":[11],"practice.":[12],"We":[13,40],"evaluated":[14],"13":[15],"TKIs":[16],"(gefitinib,":[17],"imatinib,":[18],"erlotinib,":[19],"nilotinib,":[20],"pazopanib,":[21],"masatinib,":[22],"sunitinib,":[23],"sorafenib,":[24],"regorafenib,":[25],"lapatinib,":[26],"vandetanib,":[27],"cediranib,":[28],"and":[29,68,81,100,147,157,171,220],"crizotinib)":[30],"for":[31,205],"their":[32],"sensitizing":[33],"effects":[34],"on":[35,182,192],"P-gp-overexpressing":[36,92,136,233],"drug-resistant":[37,111,218],"KBV20C":[38,93,98,112,137,183,194],"cells.":[39,94,195,208],"found":[41,107,166],"that":[42,73,121,129,141,167,198,222],"crizotinib":[43,105,122,142,158,170,199,224],"had":[44,187],"a":[45,60,124,160,179,188,201],"much":[46,177],"greater":[47],"sensitization":[48,90,180,190,216],"effect":[49,181,191],"than":[50],"the":[51,77,85,215],"other":[52,117],"tested":[53],"drugs":[54],"at":[55],"relatively":[56],"low":[57],"doses.":[58],"In":[59,132,153],"detailed":[61],"quantitative":[62],"analysis":[63],"using":[64],"both":[65],"lower":[66],"doses":[67],"time-duration":[69],"treatments,":[70],"we":[71,139,165],"demonstrated":[72],"crizotinib,":[74],"increased":[76],"levels":[78],"of":[79,178,217],"apoptosis":[80],"G2":[82],"arrest,":[83],"was":[84,106],"best":[86],"TKI":[87],"to":[88,108],"induce":[89],"Upon":[95],"comparing":[96],"resistant":[97,125,206],"cells":[99,114,219],"sensitive":[101],"KB":[102],"parent":[103],"cells,":[104,138,184],"markedly":[109],"sensitize":[110],"cancer":[113,126,207],"compared":[115],"with":[116,169,231],"TKIs.":[118],"This":[119,196],"suggests":[120,197],"is":[123,200],"cell-sensitizing":[127],"drug":[128,204],"induces":[130],"apoptosis.":[131],"mice":[133],"bearing":[134],"xenografted":[135],"confirmed":[140],"significantly":[143],"reduced":[144],"tumor":[145],"growth":[146],"weight,":[148],"without":[149],"apparent":[150],"side":[151],"effects.":[152],"addition,":[154],"although":[155],"lapatinib":[156,186],"have":[159,176],"high":[161,189],"P-gp":[162],"inhibitory":[163],"activity,":[164],"co-treatment":[168],"vincristine":[172],"(VIC)":[173],"did":[174],"not":[175],"whereas":[185],"VIC-treated":[193],"single-treatment":[202],"specific":[203,232],"These":[209],"findings":[210],"provide":[211],"valuable":[212],"information":[213],"regarding":[214],"indicate":[221],"low-dose":[223],"monotherapy":[225],"may":[226],"be":[227],"patients":[230],"chemoresistant":[234],"cancer.":[235]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":5},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-05-13T00:00:00"}